keyword
https://read.qxmd.com/read/38612817/in-vitro-and-in-vivo-pharmacological-profiles-of-lenart01-a-dermorphin-ranatensin-hybrid-peptide
#1
JOURNAL ARTICLE
Nadine Hochrainer, Pawel Serafin, Sara D'Ingiullo, Adriano Mollica, Sebastian Granica, Marek Brytan, Patrycja Kleczkowska, Mariana Spetea
Diverse chemical and pharmacological strategies are currently being explored to minimize the unwanted side effects of currently used opioid analgesics while achieving effective pain relief. The use of multitarget ligands with activity at more than one receptor represents a promising therapeutic approach. We recently reported a bifunctional peptide-based hybrid LENART01 combining dermorphin and ranatensin pharmacophores, which displays activity to the mu-opioid receptor (MOR) and dopamine D2 receptor (D2R) in rat brains and spinal cords...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38596426/evaluating-the-impact-of-eat-sleep-console-in-neonatal-abstinence-syndrome-treatment-for-infants-exposed-to-substance-use-in-utero
#2
JOURNAL ARTICLE
Shannon V McGrath, Allie Rivera, Christopher Kennie-Richardson, David Ehrmann, Julie Cline, Kaye Gable, Victoria Forrest
OBJECTIVE: An increase in maternal use of licit or illicit substances, alcohol, and tobacco has resulted in an increased incidence of neonatal abstinence syndrome (NAS). In recent years, NAS management has shifted to initiating an Eat, Sleep, Console (ESC) approach prior to pharmacologic treatment. The objective of this study was to evaluate the impact of ESC in combination with pharmacologic treatment in the management of NAS for infants exposed to substance use in utero . METHODS: This single system, multisite, retrospective cohort study evaluated infants with known exposure to substance or polysubstance use in utero or those who had signs and symptoms of withdrawal with a positive toxicology screen...
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38586726/effectiveness-of-erector-spinae-muscle-block-in-vertebral-oncologic-fracture
#3
JOURNAL ARTICLE
Lizeth Castillo Ramirez, María Del Rocío Guillen Nuñez, Àngel Manuel Jùarez Lemus, Ricardo Plancarte Sànchez, Viviana Andrea Villar Herrera, Gian Marco Gutierrez Herrera
Objectives An observational, retrospective, longitudinal, and analytical study aimed to evaluate the effectiveness of the erector spinae plane (ESP) block in managing pain in patients with vertebral fractures secondary to tumoral activity. This study included patients treated at the Pain Clinic who underwent ESP block. The objectives were to describe demographic characteristics, oncological diagnosis, vertebral fracture features, imaging techniques, medications used, and the level of ESP block. Additionally, pain levels were assessed using a numerical analog scale, and the consumption of opioid analgesic medications before and after the ESP block, during follow-up consultations, along with patient satisfaction...
March 2024: Curēus
https://read.qxmd.com/read/38579315/opioid-sparing-nonsteroid-anti-inflammatory-drugs-protocol-in-patients-undergoing-intramedullary-nailing-of-tibial-shaft-fractures-a-randomized-control-trial
#4
JOURNAL ARTICLE
Hans Hess-Arcelay, Alexandra Claudio-Marcano, Norberto J Torres-Lugo, David Deliz-Jimenez, Jose Acosta-Julbe, Gabriel Hernandez, Daniel Deliz-Jimenez, Gamaliel Monge, Norman Ramírez, Luis Lojo-Sojo
INTRODUCTION: Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective analgesics commonly used in fracture management. Although previously associated with delayed fracture healing, multiple studies have demonstrated their safety, with minimal risks of fracture healing. Given the current opioid crisis in the United States, alternate pain control modalities are essential to reduce opioid consumption. This study aims to determine whether the combination of oral acetaminophen and intravenous ketorolac is a viable alternative to opioid-based pain management in closed tibial shaft fractures treated with intramedullary nailing...
April 4, 2024: Journal of the American Academy of Orthopaedic Surgeons
https://read.qxmd.com/read/38577773/tiam1-mediated-maladaptive-plasticity-underlying-morphine-tolerance-and-hyperalgesia
#5
JOURNAL ARTICLE
Changqun Yao, Xing Fang, Qin Ru, Wei Li, Jun Li, Zeinab Mehsein, Kimberley F Tolias, Lingyong Li
Opioid pain medications, such as morphine, remain the mainstay for treating severe and chronic pain. Prolonged morphine use, however, triggers analgesic tolerance and hyperalgesia (OIH), which can last for a long period after morphine withdrawal. How morphine induces these detrimental side effects remains unclear. Here, we show that morphine tolerance and OIH are mediated by Tiam1-coordinated synaptic structural and functional plasticity in the spinal nociceptive network. Tiam1 is a Rac1 GTPase guanine nucleotide exchange factor (GEF) that promotes excitatory synaptogenesis by modulating actin cytoskeletal dynamics...
April 5, 2024: Brain
https://read.qxmd.com/read/38564795/is-a-rapid-recovery-protocol-for-tha-and-tka-associated-with-decreased-90-day-complications-opioid-use-and-readmissions-in-a-health-safety-net-hospital
#6
JOURNAL ARTICLE
Michael W Buchanan, Brian Gibbs, Andrew A Ronald, David Novikov, Allen Yang, Seroos Salavati, Ayesha Abdeen
BACKGROUND: Patients treated at a health safety-net hospital have increased medical complexity and social determinants of health that are associated with an increasing risk of complications after TKA and THA. Fast-track rapid recovery protocols (RRPs) are associated with reduced complications and length of stay in the general population; however, whether that is the case among patients who are socioeconomically disadvantaged in health safety-net hospitals remains poorly defined. QUESTIONS/PURPOSES: When an RRP protocol is implemented in a health safety-net hospital after TKA and THA: (1) Was there an associated change in complications, specifically infection, symptomatic deep venous thromboembolism (DVT), symptomatic pulmonary embolism (PE), myocardial infarction (MI), and mortality? (2) Was there an associated difference in inpatient opioid consumption? (3) Was there an associated difference in length of stay and 90-day readmission rate? (4) Was there an associated difference in discharge disposition? METHODS: An observational study with a historical control group was conducted in an urban, academic, tertiary-care health safety-net hospital...
April 2, 2024: Clinical Orthopaedics and related Research
https://read.qxmd.com/read/38562752/deletion-of-arrestin-3-does-not-improve-compulsive-drug-seeking-behavior-in-a-longitudinal-paradigm-of-oral-morphine-self-administration
#7
Sarah Warren Gooding, Lindsey Felth, Randi Foxall, Zachary Rosa, Kyle Ireton, Izabella Sall, Joshua Gipoor, Anirudh Gaur, Madeline King, Noah Dirks, Cheryl A Whistler, Jennifer L Whistler
Opioid drugs are potent analgesics that mimic the endogenous opioid peptides, endorphins and enkephalins, by activating the µ-opioid receptor. Opioid use is limited by side effects, including significant risk of opioid use disorder. Improvement of the effect/side effect profile of opioid medications is a key pursuit of opioid research, yet there is no consensus on how to achieve this goal. One hypothesis is that the degree of arrestin-3 recruitment to the µ-opioid receptor impacts therapeutic utility...
March 22, 2024: bioRxiv
https://read.qxmd.com/read/38496640/cannabinoid-cb-2-receptors-in-primary-sensory-neurons-are-implicated-in-cb-2-agonist-mediated-suppression-of-paclitaxel-induced-neuropathic-nociception-and-sexually-dimorphic-sparing-of-morphine-tolerance
#8
Kelsey G Guenther, Xiaoyan Lin, Zhili Xu, Alexandros Makriyannis, Julian Romero, Cecilia J Hillard, Ken Mackie, Andrea G Hohmann
Cannabinoid CB 2 agonists show therapeutic efficacy without the unwanted side effects commonly associated with direct activation of CB 1 receptors. The G protein-biased CB 2 receptor agonist LY2828360 attenuates the maintenance of chemotherapy-induced neuropathic nociception in male mice and blocks the development of morphine tolerance in this model. However, the specific cell types involved in this phenomenon have never been investigated and whether this therapeutic profile is observed in female mice remains poorly understood...
March 10, 2024: bioRxiv
https://read.qxmd.com/read/38459108/pharmacological-evaluation-and-phytochemical-profiling-of-butanol-extract-of-l-edodes-with-in-silico-virtual-screening
#9
JOURNAL ARTICLE
Umer Ejaz, Muhammad Afzal, Muhammad Naveed, Zeemal Seemab Amin, Asia Atta, Tariq Aziz, Gul Kainat, Noshaba Mehmood, Metab Alharbi, Abdullah F Alasmari
L. edodes (L. edodes) is the most consumed mushroom in the world and has been well known for its therapeutic potential as an edible and medicinal candidate, it contains dietary fibers, vitamins, proteins, minerals, and carbohydrates. In the current study butanolic extract of mushroom was used to form semisolid butanol extract. The current study aimed to explore biometabolites that might have biological activities in n-butanol extract of L. edodes using FT-IR and GC-MS and LC-MS. The synergistic properties of bioactive compounds were futher assessed by performing different biological assays such as antioxidant, anti-inflammatory and antidiabetic...
March 8, 2024: Scientific Reports
https://read.qxmd.com/read/38452211/ketogenic-diet-mitigates-opioid-induced-hyperalgesia-by-restoring-short-chain-fatty-acids-producing-bacteria-in-the-gut
#10
JOURNAL ARTICLE
Joshua Crawford, Sufang Liu, Ran Tao, Phillip Kramer, Steven Bender, Feng Tao
Opioids are commonly prescribed to patients with chronic pain. Chronic opioid usage comes with a slew of serious side effects, including opioid-induced hyperalgesia (OIH). The patients with long-term opioid treatment experience paradoxical increases in nociceptive hypersensitivity, namely, OIH. Currently, treatment options for OIH are extremely lacking. In this study, we show that the ketogenic diet recovers the abnormal pain behavior caused by chronic morphine treatment in male mice, and we further show that the therapeutic effect of the ketogenic diet is mediated through gut microbiome...
March 6, 2024: Pain
https://read.qxmd.com/read/38451024/antinociceptive-and-adverse-effects-of-morphine-ketamine-mixtures-in-rats
#11
JOURNAL ARTICLE
Conor D Strumberger, Evangeline J D'Epagnier, Kevin H Nguyen, John D Rogers, Matthew P Meyer, Yashmita Malhotra, Jillian E Hinman, Elisabeth L Jansen, Vanessa Minervini
Prescription opioids are the gold standard for treating moderate to severe pain despite their well-documented adverse effects. Of all prescription medications, opioids are abused most widely, and fatal overdoses have reached epidemic levels. One strategy for improving the margin of safety of opioids is combining them with non-opioid drugs to decrease the opioid dose needed for pain relief, thereby reducing adverse effects that occur with larger doses. The N-methyl-D-aspartate receptor antagonist ketamine has been used safely as an analgesic but only under a very limited range of conditions...
April 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38406346/developing-mathematical-models-to-compare-and-analyse-the-pharmacokinetics-of-morphine-and-fentanyl
#12
JOURNAL ARTICLE
Prathvi Shenoy, Mahadev Rao, Shreesha Chokkadi, Sushma Bhatnagar, Naveen Salins
BACKGROUND AND AIMS: The two-compartment model is generally used in pharmacokinetics to illustrate the distribution and excretion of drugs. In this study, we evaluated the distribution patterns of morphine and fentanyl by using a two-compartment model. METHODS: Using numeric analysis techniques, non-linear ordinary differential equations were used to mathematically analyse drug distribution, transition, and concentration in the body compartments. Math Works, Inc...
January 2024: Indian Journal of Anaesthesia
https://read.qxmd.com/read/38380802/roles-of-lnclingo2-and-its-derived-mir-876-5p-in-the-acquisition-of-opioid-reinforcement
#13
JOURNAL ARTICLE
Hongyu Yang, Xiuning Zhang, Minglong Zhang, Yun Lu, Bing Xie, Shaoguang Sun, Hailei Yu, Bin Cong, Yixiao Luo, Chunling Ma, Di Wen
Recent studies found that non-coding RNAs (ncRNAs) played crucial roles in drug addiction through epigenetic regulation of gene expression and underlying drug-induced neuroadaptations. In this study, we characterized lncRNA transcriptome profiles in the nucleus accumbens (NAc) of mice exhibiting morphine-conditioned place preference (CPP) and explored the prospective roles of novel differentially expressed lncRNA, lncLingo2 and its derived miR-876-5p in the acquisition of opioids-associated behaviours. We found that the lncLingo2 was downregulated within the NAc core (NAcC) but not in the NAc shell (NAcS)...
February 2024: Addiction Biology
https://read.qxmd.com/read/38332016/trna-epitranscriptomic-alterations-associated-with-opioid-induced-reward-seeking-and-long-term-opioid-withdrawal-in-male-mice
#14
JOURNAL ARTICLE
Jennifer Blaze, Caleb J Browne, Rita Futamura, Behnam Javidfar, Venetia Zachariou, Eric J Nestler, Schahram Akbarian
DNA cytosine methylation has been documented as a potential epigenetic mechanism of transcriptional regulation underlying opioid use disorder. However, methylation of RNA cytosine residues, which would drive another level of biological influence as an epitranscriptomic mechanism of gene and protein regulation has not been studied in the context of addiction. Here, we probed whether chronic morphine exposure could alter tRNA cytosine methylation (m5 C) and resulting expression levels in the medial prefrontal cortex (mPFC), a brain region crucial for reward processing and executive function that exhibits opioid-induced molecular restructuring...
February 8, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38318132/j-2156-a-small-molecule-somatostatin-type-4-receptor-agonist-alleviated-hindpaw-hypersensitivity-in-the-streptozotocin-induced-rat-model-of-painful-diabetic-neuropathy-but-with-a-2-fold-decrease-in-potency-at-an-advanced-stage-in-the-model-mimicking-morphine
#15
JOURNAL ARTICLE
A Kuo, M Z Imam, R Li, L Lin, A Raboczyj, A E Bohmer, J R Nicholson, L Corradini, M T Smith
There is a large unmet need for novel pain-killers to improve relief of painful diabetic neuropathy (PDN). Herein, we assessed the efficacy of the somatostatin type 4 (SST4 ) receptor agonist, J-2156, for relief of PDN in rats. Diabetes was induced with streptozotocin (STZ; 70 mg/kg) and bilateral hindpaw hypersensitivity was fully developed by 8-week post-STZ. In the intervals, 8-12-weeks (morphine-sensitive phase; Phase 1) and 16-18-weeks (morphine-hyposensitive phase; Phase 2) post-STZ, rats received a single dose of intraperitoneal (i...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38301534/hcn1-in-the-lateral-habenula-contributes-to-morphine-abstinence-induced-anxiety-like-behaviors-in-male-mice
#16
JOURNAL ARTICLE
Zonghui Li, Qigang Shu, Qiuping Chen, Hongwei Yang, Lu Liu, Zhi He, Hong Lin, Zicheng Li
Anxiety disorders, common symptoms during morphine withdrawal, are important negative reinforcement factors leading to relapse. Lateral habenula serves as a negative reinforcement center, however its role in morphine withdrawal-induced anxiety remains uncovered. The hyperpolarization activated cyclic nucleotide-gated (HCN) channels have been reported to be important in emotion processing and addiction, but the role of HCN in anxiety from drug protracted abstinence remains elusive. In this study, by using behavioral test, Western blot, immunofluorescence, electrophysiology and virus-mediated regulation of HCN, we found that: (1) Intra-LHb injection of selective HCN blocker ZD7288 alleviated anxiety-like behaviors in morphine protracted abstinent male mice...
January 28, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38293046/negative-allosteric-modulation-of-cb1-cannabinoid-receptor-signaling-decreases-intravenous-morphine-self-administration-and-relapse-in-mice
#17
Idaira Oliva, Fezaan Kazi, Lucas N Cantwell, Ganesh A Thakur, Jonathon D Crystal, Andrea G Hohmann
The endocannabinoid system interacts with the reward system to modulate responsiveness to natural reinforcers, as well as drugs of abuse. Previous preclinical studies suggested that direct blockade of CB1 cannabinoid receptors (CB1R) could be leveraged as a potential pharmacological approach to treat substance use disorder, but this strategy failed during clinical trials due to severe psychiatric side effects. Alternative strategies have emerged to circumvent the side effects of direct CB1 binding through the development of allosteric modulators...
January 19, 2024: bioRxiv
https://read.qxmd.com/read/38272671/-phencyclidine-like-abuse-liability-and-psychosis-like-neurocognitive-effects-of-novel-arylcyclohexylamine-drugs-of-abuse-in-rodents
#18
JOURNAL ARTICLE
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Abuse of novel arylcyclohexylamines (ACX) poses risks for toxicities including adverse neurocognitive effects. In vivo effects of ring-substituted analogs of phencyclidine (PCP), eticyclidine (PCE), and ketamine are understudied. Adult male NIH Swiss mice were used to assess locomotor effects of PCP and its 3-OH, 3-MeO, 3-Cl and 4-MeO analogs; PCE and its 3-OH and 3-MeO analogs; and ketamine and its deschloro and 2F-deschloro analogs, in comparison to those of methamphetamine (METH), 3,4-methylenedioxymethamphetamine (MDMA), and two benzofuran analogs of MDMA...
January 25, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38258095/vaccines-to-treat-substance-use-disorders-current-status-and-future-directions
#19
REVIEW
Tangsheng Lu, Xue Li, Wei Zheng, Chenyan Kuang, Bingyi Wu, Xiaoxing Liu, Yanxue Xue, Jie Shi, Lin Lu, Ying Han
Addiction, particularly in relation to psychostimulants and opioids, persists as a global health crisis with profound social and economic ramifications. Traditional interventions, including medications and behavioral therapies, often encounter limited success due to the chronic and relapsing nature of addictive disorders. Consequently, there is significant interest in the development of innovative therapeutics to counteract the effects of abused substances. In recent years, vaccines have emerged as a novel and promising strategy to tackle addiction...
January 8, 2024: Pharmaceutics
https://read.qxmd.com/read/38255163/fibromyalgia-animal-models-using-intermittent-cold-and-psychological-stress
#20
REVIEW
Hiroshi Ueda, Hiroyuki Neyama
Fibromyalgia (FM) is a chronic pain condition characterized by widespread musculoskeletal pain and other frequent symptoms such as fatigue, sleep disturbance, cognitive impairment, and mood disorder. Based on the view that intermittent stress would be the most probable etiology for FM, intermittent cold- and intermittent psychological stress-induced generalized pain (ICGP and IPGP) models in mice have been developed and validated as FM-like pain models in terms of the patho-physiological and pharmacotherapeutic features that are shared with clinical versions...
December 25, 2023: Biomedicines
keyword
keyword
87267
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.